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815A Choreography of Nicotinic
Receptors Directs the Dopamine
Neuron Routine
Modulation of the mesocorticolimbic dopamine sys-
tem by nicotinic acetylcholine receptors (nAChRs) is
thought to play an important role in both health and ad-
diction. However, a clear understanding of how these
receptors regulate in vivo firing activity has been elu-
sive. In this issue of Neuron, Mameli-Engvall and col-
leagues report an impressive and thought-provoking
series of in vivo experiments combining single-unit
recordings from dopamine neurons with nAChR sub-
unit deletions and region-specific lentiviral subunit
re-expression.
Ventral tegmental area (VTA) dopamine neurons play a
crucial role in reward processing (Schultz, 2002). They
are a common target for drugs of abuse and are thought
to play a central role in the development of addiction
(Nestler, 2005). Nicotine activates the dopamine system
through multiple effects at a rich diversity of nicotinic
acetylcholine receptors (nAChRs). Recent studies have
begun to reveal how nAChRs modulate synapses and
membrane excitability in the VTA. For example, nicotine
can have direct excitatory effects on dopamine neurons
through b2-subunit-containing receptors and increases
glutamate release onto dopamine neurons through a7-
subunit-containing nAChRs. In addition, b2-nAChRs on
GABAergic interneurons rapidly desensitize in response
to nicotine, which reduces a tonic excitatory action of
acetylcholine on these neurons, thereby reducing their
inhibitory input onto dopamine neurons (Mansvelder
and McGehee, 2002; Pidoplichko et al., 2004). Our un-
derstanding, however, of how this functional diversity
is related to the regulation of dopamine neuron firing
in vivo has been relatively limited.
Dopamine neurons are spontaneously active and
switch between a single-action-potential pattern that
can be regular or irregular and a bursting pattern where
they fire two to three (sometimes more) action potentials
in rapid bursts. Bursts are thought to be the means
through which dopamine neurons signal reward predic-tion error (Schultz, 2002). Bursts are thought to crucially
influence extracellular dopamine levels through the bal-
ance of release and uptake combined with short-term
plasticity. It is known that nicotine can increase firing
rate and bursting in dopamine neurons. Pharmacologi-
cal studies in vivo have begun to suggest that bursting
activity and firing rate might be differentially governed
by discrete nAChR subpopulations: a7-subunit-contain-
ing receptors have been suggested to promote nicotine-
induced bursting, whereas non-a7-subunit-containing
receptors promote an increase in firing rate (Schilstrom
et al., 2003). These studies, however, must be viewed
cautiously because it is difficult to be sure of the exact
subunit specificity of the agonists and antagonists used.
In addition, besides the action of nicotine, little is known
about how endogenous acetylcholine (ACh) regulates in
vivo dopamine neuron activity through nAChRs.
In this issue of Neuron, Mameli-Engvall et al. (2006)
report a series of intriguing studies recording from
dopamine neurons, in vivo, in anesthetized mice with
different nAChR subunit deletions. As a first step, they
characterized firing rate and pattern in wild-type mice
and show that firing activity can be classed as either
low-firing/low-bursting (LFLB), low-firing/high-bursting
(LFHB), high-firing/low-bursting (HFLB) or high-firing/
high-bursting (HFHB). The merits of this scheme become
more obvious when firing activity is observed in the
knockout mice. In mice with a deletion for the b2 subunit,
dopamine neurons fall almost entirely into the LFLB cate-
gory. In mice with a deletion for the a7 subunit, dopamine
neurons are either LFLB or HFHB. This is a somewhat
surprising result. What does it mean? Mameli-Engvall
et al. suggest that ACh acting at b2-subunit-containing
receptors plays an obligatory role in switching dopa-
mine neurons into any state of increased excitability
(high-firing and/or high-bursting). They suggest that
the role of the a7 subunit is more subtle: it helps sculpt
this increased excitability into the more complex states
of either LFHB or HFLB. This is a somewhat speculative
suggestion, but it is an interesting and provocative
notion that also provides some purpose for the subunit
diversity.
Although these results suggest that the b2 subunit
plays an obligatory role in switching dopamine neurons
to states of increased firing and/or bursting, they do not
tell us much about the neuroanatomical location of the
crucial receptors. Next, therefore, Mameli-Engvall et al.
show that selective lentiviral re-expression of this sub-
unit in the VTA restores all four modes of firing. It seems,
therefore, that the effects of nicotine on both firing rate
and bursting require b2-containing nAChRs in the VTA.
This is consistent with earlier studies showing that b2-
containing nAChRs in the VTA are required for nicotine
reinforcement (Picciotto et al., 1998; Maskos et al.,
2005). However, b2-containing nAChRs are expressed
in both dopaminergic and GABAergic neurons in the
VTA. Indeed, the direct cholinergic innervation of dopa-
minergic cells may be relatively limited, which suggests
that the effects at GABAergic neurons are likely to be
important (Garzon et al., 1999). Further studies are
therefore required to tease out the contribution of b2 re-
ceptors in each cell type.
So far this is quite a bit to digest, but there’s more. They
go on to examine the effects of nicotine on dopamine
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816neurons in the knockout mice, and the results are simi-
larly interesting and thought provoking. Previously, it
has been shown that nicotine increases both firing rate
and bursting in dopamine neurons. However, closer in-
spection using their new categorization scheme shows
that, in fact, LFLB neurons increase their firing rate, but
not bursting activity. Neurons in other modes increase
both firing and bursting. Interestingly though, most neu-
rons do not switch mode. For example, although most
LFLB neurons increase firing in response to nicotine,
they remain within the boundaries of the LFLB mode.
What about the knockout mice? First, nicotine has no
effect on firing rate or bursting in b2 knockout mice.
This is consistent with the suggestion that the b2 sub-
unit is essential for dopamine neurons to switch into
any of the more excitable modes. The results for the
a7 knockout mice are more complex and challenging
to interpret. In these mice, nicotine still increases firing
rate, although to a lesser degree than in wild-types, but
it has no effect on bursting. Again, closer examination
of individual neurons is revealing. It turns out that
around half of the neurons increase their firing rate
and/or bursting and half decrease their firing rate and/
or bursting. This is at least consistent with the notion
put forth earlier in the paper that a7-containing nAChRs
are involved in the ‘‘fine tuning’’ of dopamine neuron
activity. What this really means in terms of detailed
underlying mechanisms remains to be determined, but
we are for now presented with some food for thought.
Implicit in the authors’ theorizing is the idea that dopa-
mine neurons can move between all four modes of activ-
ity. One alternative possibility, however, is that there are
functionally distinct subgroups of dopamine neurons. It
may be, for example, that one subgroup always exhibits
LFLB, whereas a second subgroup can be in one of the
three more excitable modes. It is conspicuous that in
most cases individual neurons do not switch mode in re-
sponse to nicotine. Here, parallels must be drawn with
the nAChR expression literature (e.g., distinct subtypes
of dopamine and GABA neurons can been seen by their
distinct expression profiles of different nAChR subunits
[Klink et al., 2001]).
Where next? Perhaps the most pressing challenge for
the future will be to resolve the role of a7-containing ver-
sus other nAChRs in more detail. Although a7 subunits
are only a minority among the diversity of nAChR sub-
units expressed in the VTA, their role in the regulation
of dopamine neuron physiology seems intriguing—
how does this relate to the effects of a7-containing
nAChR on glutamate release? It will also be important
to understand their role not just in the regulation of do-
pamine neuron activity, but also in terms of the behav-
ioral effects of nicotine. For example, despite the conse-
quences of the a7-subunit deletion on the physiology of
individual dopamine neurons, a7-subunit knockout mice
nevertheless continue to show nicotine conditioned
place-preference (Walters et al., 2006). And what of the
other subunits, (e.g., a3, 4, 5, and 6), in the choreography
of nicotinic cholinergic function?
One final point that is worth keeping in mind is that
ultimately the actions of dopamine neurons are effected
through dopamine release. Recent studies have shown
that the direct modulation of release by nAChRs at
axon terminals is also powerful and sophisticated (Riceand Cragg, 2004; Zhang and Sulzer, 2004), and, there-
fore, a full understanding of how ACh modulates the
dopamine system will require an integrated approach
across many fields. Nonetheless, this study represents
an important step in the right direction and, more gener-
ally, a stimulating illustration of what can be achieved
by combining traditional experimental approaches with
modern molecular biology.
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